Twinbeech Capital »

Halozyme Therapeutics shares owned by Twinbeech Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Twinbeech Capital from 13F filings

Historical chart of Twinbeech Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Twinbeech Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Twinbeech Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.1M 159k 57.24
2023-12-31 $8.2M 222k 36.96
2023-09-30 $6.9M 181k 38.20
2023-03-31 $7.9M 207k 38.19
2022-12-31 $284k 5.0k 56.90
2020-12-31 $231k 5.4k 42.71